News & insights

29 May 2025 - Pharmaceutical patent strategy: building a portfolio to maximise value

Events

29 May 2025 - Pharmaceutical patent strategy: building a portfolio to maximise value

An optimal pharmaceutical patent portfolio maximises the value of a drug, providing long term, robust patent protection to weather the storm of generic product launches, whilst also navigating a compl...

Sanofi vs Amgen: The UPC decides on second medical use claims

Case law

Sanofi vs Amgen: The UPC decides on second medical use claims

The Dusseldorf local division has last week handed down the first decision from the UPC relating to second medical use claims. Here, we discuss what can be gleaned from this first instance decision re...

Challenges of extending expired patent rights through trade marks in the medical implant market: Insights from AG Biondi’s Opinion in Case C-17/24

Case law

Challenges of extending expired patent rights through trade marks in the medical implant market: Insights from AG Biondi’s Opinion in Case C-17/24

Trade marks can offer very powerful complementary and long-lasting benefits for companies once their patents expire. The term of protection of a patent can give its owner a precious period in which to...

How RNA therapeutics are shaping the future of mental health treatment

Thoughts

How RNA therapeutics are shaping the future of mental health treatment

This Mental Health Awareness Week, we wanted to highlight how the fast-moving field of RNA therapeutics is being leveraged to treat mental health disorders such as anxiety and depression. We will cove...

30 April 2025 - RNA technologies: pitfalls and patent drafting tips in Europe

Events

30 April 2025 - RNA technologies: pitfalls and patent drafting tips in Europe

In the wake of vaccine development during the COVID-19 pandemic, the value of RNA technologies is at an all-time high.

Requesting a Unitary Patent – What do I need to know?

Thoughts

Requesting a Unitary Patent – What do I need to know?

Since the changes to the European patent system which led to the introduction of the Unitary Patent (UP) and the Unified Patent Court (UPC), we have been assisting more and more clients with obtaining...

Opposition Hotspots: Which medical technology sectors face the highest rate of EPO opposition?

Thoughts

Opposition Hotspots: Which medical technology sectors face the highest rate of EPO opposition?

Which MedTech sectors see the most oppositions at the EPO? Which MedTech patents are safer from being revoked or limited via EPO opposition?

Can “public prior use” be relied upon to invalidate European patents?

Thoughts

Can “public prior use” be relied upon to invalidate European patents?

The “state of the art” for assessing novelty and inventive step at the European Patent Office includes “…everything made available to the public by means of a written or oral description, by use, or i...

LNPs: Small lipids, big potential in nucleic acid delivery

Thoughts

LNPs: Small lipids, big potential in nucleic acid delivery

Lipid nanoparticles (LNPs) have emerged as a leading pharmaceutical formulation technology, particularly for nucleic acid delivery.

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us